Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
about
Renal tumors: diagnostic and prognostic biomarkersTargeted therapeutic strategies for the management of renal cell carcinomaThe metabolic basis of kidney cancerDifferential diagnosis of renal tumors with tubulopapillary architecture in children and young adults: a case report and review of literature.Diagnostic approach to eosinophilic renal neoplasmst(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed casesFactors impacting survival in children with renal cell carcinoma.Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumMolecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersNon-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeuticsTranslocation renal cell carcinomas in adults: a single-institution experience.Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signalingXp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.Percutaneous renal tumour biopsy.RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.Pediatric Papillary Renal Cell Carcinoma in a Horseshoe Kidney: A Case Report with Review of the Literature.Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.TFE3 regulates renal adenocarcinoma cell proliferation via activation of the mTOR pathway.ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21.Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas.Fine-needle aspiration findings of Xp11 translocation renal cell carcinoma metastatic to a hilar lymph node.TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity.TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.Cardiopulmonary bypass-assisted surgery for the treatment of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a tumor thrombus within the inferior vena cava: A case reportRenal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity.Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation.Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.MicroRNA expression profiling of Xp11 renal cell carcinoma.Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma.[The translocation carcinoma: A pediatric renal tumor also in adults].Unsuspected Xp11 Translocation Renal Neoplasm Associated With Contralateral Clear Cell Carcinoma.Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
P2860
Q26860500-48F4AF2E-C342-429A-95A8-A24788D99149Q27013846-7A5B3D90-1B8F-4360-900C-BA5BAC081535Q27023273-78164556-35FE-41B5-B0D2-A64C73B64E90Q34448223-DED3136D-0FFA-4EB2-A903-388197A15FC0Q35155653-C229DD52-18B0-44BC-A580-DDFBD6FB8088Q35207508-743BC39D-873A-4591-B4D9-7A2153BBF111Q35630125-A03D7C37-6FB9-4EC9-8E4E-4897FE8215D9Q35636323-BCEA5C26-0501-4CC2-9D77-ABB4B3808666Q36001179-BB62D020-4E56-4652-9798-792D1BD29901Q36182819-238A78F9-0810-491A-9699-688F16464634Q36253658-D79CBDAB-8733-4213-BB1A-432B5C6835ECQ36354841-155340DD-DA74-4A30-85FC-50B217F0BB44Q36481657-4E4B0424-73B4-4B8C-8899-9F07FB5F84D9Q37284328-F30D1101-16A3-4079-AED4-6F7B8933D843Q37452237-B62733FA-F4B4-4671-BC3D-63B03AAB7C77Q37549886-E005E631-0352-42B1-806E-9DD926A89C4CQ37623118-645702EC-BC91-4AC5-831C-6810F66B843BQ37836508-F1758D58-AF65-4985-A429-0264D5EEA84CQ38231652-1BE5ECED-FAE7-4E9A-ABA0-7BFE18D4BCEFQ38375566-C2B0E6DF-9677-4280-A964-6D8857B8C76BQ38388597-B857D0E4-B805-4985-AAD3-27FB882C3B0AQ38572371-1FBA9E19-86F4-4F81-B05F-2622483E04C5Q38670018-8B8C5563-61DF-45A6-B216-5FE41D330BAEQ38697205-571591B2-C290-4368-82A6-30A0DC2E067CQ38743525-0DA7E876-DEB5-4D10-9138-BC0AF3D1C110Q39010157-16FC3737-FF36-4802-8004-F13072B4584FQ39129490-0695E0E1-57AA-44E9-996F-AFB5680BD6D3Q39450579-30685D8A-8A7B-4F96-8938-54B8E58CE872Q39922019-52A91935-0291-4EA0-955A-E2666C9494FCQ41670942-6CCB378F-15BB-445E-AA94-9CC54114BF7EQ42215445-51657545-4E9D-422E-A51F-180BE09FAB37Q42465071-24D163F1-19DF-4B3B-BD3B-FCEA72A00F8AQ45867795-2E7DB625-E33A-44C5-93FE-591A1CCBEA41Q48246775-980E6F98-9B78-40A7-8098-759D13860BCEQ50726690-A3E12866-7EC9-4963-BCFC-6387ED964AFEQ51723795-EEBF5D82-FD7D-406C-80EF-A5AEF71C356DQ53119149-5BC7E62B-B695-487E-B3A2-82837C3BF043Q53149212-C0309CDD-7381-4300-8A01-4DC3DDADE39EQ53220937-ACF71AC4-DF97-4BB4-9D5E-A2C4FADF4467Q53246289-04AA1ED1-BA9B-4AB6-8212-7496D118E101
P2860
Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@ast
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@en
type
label
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@ast
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@en
prefLabel
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@ast
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@en
P2093
P2860
P1476
Xp11 translocation renal cell ...... emphasizing novel RCC markers.
@en
P2093
Angelo M De Marzo
George J Netto
Jessica Hicks
Pedram Argani
Peter B Illei
Roula Albadine
Victor E Reuter
P2860
P304
P356
10.1097/PAS.0B013E3181E8CE5B
P407
P50
P577
2010-09-01T00:00:00Z